Vesigen Therapeutics

Non-viral delivery platform for intracellular therapeutics using ARMMs technology

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups27 employees language vesigen.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 4 times.

YearFilings
20241

Investor mix

5 investors on record; lead investors include Morningside, Leaps by Bayer.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon